"HOW TO" GUIDE FOR CLINICIANS INTERESTED IN BECOMING INVOLVED IN CLINICAL STROKE RESEARCH

Clinical stroke research is typically performed within the domain of large academic medical centers led by stroke specialists generally well versed in clinical trial methodology and performance. Practitioners who see and treat patients with stroke on a regular basis, either as inpatients acutely or as outpatients after the acute hospitalization, have the opportunity to help advance stroke care by testing the same new and promising therapies that are being employed at academic medical centers. This chapter provides an overview of clinical trial structure and implementation that we hope will provide impetus to the practitioner to consider becoming involved in stroke clinical trials. The benefits to practitioners include providing the same promising treatments that patients receive at tertiary care stroke centers, greater patient satisfaction in knowing they are getting state-of-the-art care, enhanced referral patterns, and financial remuneration, among others. Topics covered include resources needed, relationship to academic medical centers, ethical and institutional review board issues, patient perspective, budget, recruitment, informed consent, data collection and management, safety, outcome measures, and lessons from other diseases.

[1]  U. Bogdahn,et al.  Long-term outcome after thrombolysis in telemedical stroke care , 2007, Neurology.

[2]  Wade S. Smith,et al.  Effect of a US National Institutes of Health programme of clinical trials on public health and costs , 2006, The Lancet.

[3]  P. Tfelt-Hansen Understanding clinical trials in migraine , 2006, The Journal of Headache and Pain.

[4]  Robert J Adams,et al.  Telestroke: extending stroke expertise into underserved areas , 2006, The Lancet Neurology.

[5]  B. Worrall,et al.  Practice-based clinical research and ethical decision making--Part II: deciding whether to host a particular research study in your practice. , 2006, Seminars in neurology.

[6]  B. Worrall,et al.  Practice-based clinical research and ethical decision making--Part I: deciding whether to incorporate practice-based research into your clinical practice. , 2006, Seminars in neurology.

[7]  S. Johnston,et al.  Recruiting Subjects for Acute Stroke Trials: A Meta-Analysis , 2006, Stroke.

[8]  Marc Fisher,et al.  Developing and implementing future stroke therapies: The potential of telemedicine , 2005, Annals of neurology.

[9]  F. Gilliam Epilepsy – success in clinical practice: translating trials to practice , 2005, European journal of neurology.

[10]  Elizabeth W. Staton,et al.  Practice-Based Research Network Studies in the Age of HIPAA , 2005, The Annals of Family Medicine.

[11]  D. Ford,et al.  Beliefs and Attitudes Associated With the Intention to Not Accept the Diagnosis of Depression Among Young Adults , 2005, The Annals of Family Medicine.

[12]  L. Newby,et al.  The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis. , 2004, Circulation.

[13]  Robert L. Jesse,et al.  The Clinician as Investigator: Participating in Clinical Trials in the Practice Setting , 2004, Circulation.

[14]  P. Hu,et al.  Telemedicine for Acute Stroke: Triumphs and Pitfalls , 2003, Stroke.

[15]  M. Spillman,et al.  Managing conflicts of interest in the conduct of clinical trials. , 2002, JAMA.

[16]  A. Demchuk,et al.  Acute stroke care in non-urban emergency departments , 2001, Neurology.

[17]  A. Chappell Pearls and pitfalls of clinical trial investigation: should I get involved in the drug development process? , 2001, Seminars in neurology.

[18]  R. Beran,et al.  Conduct of Trials in Private Clinical Practice , 2000, Epilepsia.

[19]  D. Wade,et al.  Outcome measures in acute stroke trials: a systematic review and some recommendations to improve practice. , 2000, Stroke.

[20]  D. Emerich Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? , 2000, Trends in Neurosciences.

[21]  R. Prescott,et al.  Barriers to participation in randomised controlled trials: a systematic review. , 1999, Journal of clinical epidemiology.

[22]  J. Keyser,et al.  Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? , 1999, Trends in Neurosciences.

[23]  S. Levine,et al.  "Telestroke" : the application of telemedicine for stroke. , 1999, Stroke.

[24]  R. Adams,et al.  Acute stroke treatment trials in the United States. Rethinking strategies for success. , 1995, Stroke.

[25]  R. Beran,et al.  Clinical Trials of Antiepileptic Drugs Performed in the Private Practice Setting , 1994, Epilepsia.

[26]  J. Rothrock,et al.  Ultra-rapid identification, triage, and enrollment of stroke patients into clinical trials. , 1994, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[27]  R. Rodnitzky,et al.  Thalamic ependymoma presenting as recurrent subarachnoid hemorrhage. , 1992, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[28]  D. Lougson,et al.  Acute. , 2020, The Manchester medical gazette.